Douglas S. Ingram, President & CEO at Sarepta Therapeutics, Inc. (SRPT), bought 50,052 shares at $79.94 ($4.0M) on 2021-11-17, disclosed to the SEC on 2021-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.94 | 25,026 | $2.0M | 50.0% |
| 2 | $79.94 | 25,026 | $2.0M | 50.0% |
| Total | $79.94 avg | 50,052 | $4.0M | 100% |
| Filing → |
| SRPT | BUY | 2019-08-12 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-10-30 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-08-16 | $2.0M | — | Filing → |